Gene therapy is a new kind of specialty medical treatment. A patient receives a one-time injection of DNA-filled viruses, and those viruses get to work changing the way a patient's cells react. So far, three gene therapy treatments have been approved by the U.S. Food and Drug Administration: two are CAR T-cell immunotherapy treatments used for fighting leukemia, and one treats ... Continue Reading »
health
A Matter of Time: Why the Clock is Ticking on Stop-Loss Reinsurance
As cutting-edge science leads to new, high-cost drugs and therapies, insurers are seeing uncapped claims costs grow higher. Stop-loss reimbursements generally are on the rise, with an increasing number of employers being reimbursed for a stop-loss claim every year. ... Continue Reading »
Healthcare & Cyber Risk – Takeaways
Here are the five key takeaways from the study Holding Healthcare to Ransom by Marsh & McLennan Companies Asia Pacific Risk Center. ... Continue Reading »
Healthcare & Cyber Risk – Takeaways
We conclude the series on Healthcare & Cyber Risk by listing the five key takeaways from the study Holding Healthcare to Ransom by Marsh & McLennan Companies Asia Pacific Risk Center. ... Continue Reading »
Healthcare & Cyber Risk – Cyber Insurance to Manage Exposure
Key risks that healthcare organizations face today include patient data exposure, shared system data exposure and employee exposure. Recognizing that cyber risks cannot be eliminated, healthcare organizations are beginning to look to insurance or cyber risk transfer programs as a way to shift the risks, not just as a solution for balance sheet protection but also for ... Continue Reading »
Healthcare & Cyber Risk – The Need to Distribute Cyber Risk Management
Cyber risk management in the healthcare industry is still perceived to be driven by the IT department only, rather than overall enterprise risk management. According to healthcare respondents in the study Holding Healthcare to Ransom by Marsh & McLennan Companies Global Cyber Risk, 83 percent indicated that responsibility for cyber risk sits mainly with IT professionals and ... Continue Reading »
Healthcare Target of Increased Cyberattacks
Over the past decade, the healthcare industry has been haunted by headlines of data breaches. Three of the largest reported incidents impacting healthcare organizations in 2015 alone affected more than 100 million patient records and resulted in hundreds of millions of dollars in settlements. Data and cyber breaches have real financial and reputational impacts. ... Continue Reading »
Holding Healthcare to Ransom – Healthcare Industry’s Fight Against Cyberattacks
Healthcare is one of the industries most vulnerable to cyberattacks. The high stakes – human lives and sensitive data – make healthcare the perfect target for cybercrime. ... Continue Reading »
Understanding Systemic Cyber Risk; Insights Through Pandemic Behavior
Jeremy S. Platt, U.S. Cyber Specialty Practice Leader, Guy Carpenter; Bruce Hamory M.D., Chief Medical Officer for Health and Life Sciences at Oliver Wyman Consulting and Christopher Shafer, Assistant Vice President, Guy Carpenter Contact Jeremy S. Platt is Managing Director and U.S. Cyber Specialty Practice Leader at Guy Carpenter; Bruce Hamory, M.D. is a Partner and ... Continue Reading »
The Transfer of Pandemic Risk from the Public Sector
Here we review recent GC Capital Ideas posts on pandemic risk and the role of the capital markets to transfer risk from the public sector. ... Continue Reading »
